# DESCRIPTION

## BACKGROUND OF THE INVENTION

- motivate gene-specific demethylation

## SUMMARY OF THE INVENTION

- introduce CROs for reducing DNA methylation
- describe CRO structure and function
- specify CRO length and complementarity
- describe CRO targeting moiety
- introduce pharmaceutical composition
- describe method of treating cancer
- describe method of treating genetic disorder
- describe method of preparing CRO
- describe method of identifying CRO
- summarize invention
- describe method of diagnosing
- specify extra-coding RNA
- describe RNA oligonucleotide synthesis
- describe RNA oligonucleotide administration
- list modified nucleotides
- describe therapeutic agents
- specify genes
- describe gene ontology categories
- specify DNMT

## DEFINITIONS

- define chimeric RNA oligonucleotide
- define complementarity
- define complex binds to DNA methyltransferase
- define cytidine analog
- define demethylating agent
- define DNA methyltransferase
- define extra-coding RNA

## DETAILED DESCRIPTION

- motivate CROs for gene-specific demethylation
- describe CRO structure and application

### Chimeric RNA Oligonucleotides

- define chimeric RNA oligonucleotides
- describe binding to DNMT and ecRNA
- introduce extra-coding RNA targets
- provide exemplary gene targets and sequences
- define chimeric RNA oligonucleotides
- design gene-specific sequences
- describe methods of identifying ecRNAs
- categorize genes in cluster C
- list gene ontology categories
- provide gene ontology accessions numbers
- list genes in RNA processing
- provide gene information
- list gene abbreviations
- provide gene full names
- list gene accession numbers
- provide gene chromosome locations
- list RNA-binding proteins
- list RNA-processing proteins
- list transcription factors
- list splicing factors
- list translation initiation factors
- list other RNA-associated proteins
- list genes for cell cycle
- list genes for mRNA metabolic process
- list genes for chromosome organization
- list genes for RNA splicing
- list genes for cellular macromolecule catabolic process
- list chimeric RNA oligonucleotides
- associate with GO:0006259, DNA metabolic process
- associate with GO:0006397, mRNA processing
- associate with GO:0009057, macromolecule catabolic process
- associate with GO:0022402, cell cycle process
- list chimeric RNA oligonucleotides
- associate with GO:0006325, chromatin organization
- associate with GO:0000278, mitotic cell cycle
- associate with GO:0016568, chromatin modification
- associate with GO:0010605, negative regulation of macromolecule metabolic process
- list genes and gene ontology terms
- categorize genes by gene ontology terms
- describe protein catabolic processes
- describe proteolysis involved in cellular protein catabolic process
- describe cell cycle phase
- screen candidate CRO
- introduce chimeric RNA oligonucleotides
- screen candidate CRO for binding DNMTs
- design ssCRO using ecRNA segments
- identify CRO for particular gene
- determine target genes
- prepare CRO by chemical synthesis
- incorporate modified nucleotides
- use CROs in form of double-stranded chimeric RNA oligonucleotide

### Modifications to a RNA Oligonucleotide

- introduce cytidine analogs
- describe binding to DNMT
- list exemplary cytidine analogs
- describe conjugation to guanosine nucleotide
- introduce modified nucleotides
- describe modified bases
- describe modified sugars
- describe phosphorodiester linkages
- describe other backbone modifications

### Therapeutic Agents

- introduce therapeutic agents
- describe demethylating agents
- describe DNA and/or RNA polymerase inhibitors
- describe thymidylate synthase inhibitors
- describe other nucleoside analogs

### Diseases and Conditions

- list diseases treated by CROs
- describe cancer therapy using CROs
- list genes related to cancer
- describe genetic disorders treated by CROs

### Administration and Dosage

- introduce pharmaceutical compositions
- describe formulation of compositions
- list routes of administration
- describe sustained release administration
- list composition ingredients
- describe sterilization and packaging
- define therapeutically effective amount
- describe combination therapies

## EXAMPLES

### Experimental Methods

- describe cell culture methods
- outline RNA isolation and Northern Blot Analysis
- detail qRT-PCR methods
- explain primer extension and 5',3' RACE
- describe double thymidine block and cell synchronization
- outline DRB and ML-60218 treatment
- describe 5' Azacytidine treatment
- detail down-regulation of ecRNA using shRNA
- explain up-regulation of ecRNA using retrovirus vector
- describe bisulfite treatment, COBRA, and bisulfite sequencing
- describe MassARRAY technique
- outline DNA methylation analysis
- detail nuclear RNA immunoprecipitation (nRIP) protocol
- explain immunoprecipitation procedure
- describe electrophoretic gel mobility shift assays (EMSAs) and Kd determination
- outline in vitro transcription-methylation assay
- detail RNA immunoprecipitation sequencing (RIPseq) protocol
- describe reduced representation bisulfite sequencing (RRBS) protocol
- outline RNA expression profiling
- explain data integration
- perform gene ontology (GO) analysis
- conduct statistical analysis
- discuss data availability
- provide examples

### Example 1

- hypothesize non-coding RNA function
- characterize extra-coding RNAs of C/EBPa
- analyze ecRNA expression and methylation

### Example 2

- investigate functional role of ecRNAs on mRNA expression and DNA methylation
- analyze effect of ecRNA down-regulation on methylation status

### Example 3

- test binding ability of DNMT1 to C/EBPa ecRNAs
- analyze binding interactions between ecRNAs and DNMT1

### Example 4

- screen for ecRNAs having target site specificity

### Example 5

- perform RNA interference-mediated loss-of-function experiments
- perform overexpression-mediated gain-of-function experiments
- analyze effect of ecRNA on C/EBPa expression and methylation
- investigate specificity of ecRNA overexpression

### Example 6

- examine whether transcription interferes with DNMT1 methylation of DNA

### Example 7

- investigate mechanism behind ecRNA-mediated methylation pattern
- test in vivo binding of DNMT1 to ecRNA
- analyze in vitro ecRNA-DNMT1 interaction
- compare DNMT1 binding affinity for RNA and DNA

### Example 8

- motivate epitranscriptome mapping
- describe experimental approach
- analyze sequencing data
- correlate gene expression and methylation
- discuss implications and applications

## OTHER EMBODIMENTS

- incorporate by reference and scope

